Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Posten Norge sells Bring Citymail
Mandate

Posten Norge sells Bring Citymail

March 20, 2018 IT, Telecommunications and Outsourcing

Vinge has advised Posten Norge in connection with the sale of Bring Citymail to the German private equity company Allegra Capital.

Bring Citymail is the second largest actor on the Swedish market and has a turnover of approximately SEK two billion and approximately 3 600 employees. 

In 2013, Bring Citymail established a jointly-owned company together with Dagens Nyheter and Svenska Dagbladet for the distribution of mail and newspapers within the Stockholm area. In connection with Allegra Capital’s acquisition of Bring Citymail, Bring Citymail has disposed of its stake in the jointly-owned company, and the distribution of morning newspapers will be performed by a company which is jointly owned by Dagens Nyheter and Svenska Dagbladet and the distribution of mail will be performed by Bring Citymail.

Vinge’s team primarily consisted of Johan Winnerblad, Malin Ohlin, Marcus Glader, Joacim Rydergård, Mathilda Persson, Andrea Ahlgren and Michaela Cronemyr.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025